Vitamin D3 analogs: Effect on leukemic clonal growth and differentiation, and on serum calcium levels

This publication has 22 references indexed in Scilit:

• 1,25(OH)2-16ENE-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia
  Leukemia Research, 1994
• A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
  Journal of Clinical Investigation, 1993
• Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
  New England Journal of Medicine, 1991
• Synthetic analogues of vitamin D₃ with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemia
  FEBS Letters, 1987
• Treatment of myelodysplastic syndrome with 1.25‐dihydroxy‐vitamin D₃
  American Journal of Hematology, 1986
• Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells.
  Journal of Clinical Investigation, 1986
• Synthetic studies of vitamin D analogues. VII Synthesis of 20-oxa-21-norvitamin D3 analogues.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
• TREATMENT OF ADVANCED MYELODYSPLASTIC SYNDROME WITH ALFACALCIDOL
  The Lancet, 1984
• 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.
  The Journal of cell biology, 1984
• Acute Myelogenous Leukemia: A Human Cell Line Responsive to Colony-Stimulating Activity
  Science, 1978